Condition
    Moderate Evidence
    Effectiveness 2/5

    Melatonin for Frequent Night Waking

    Melatonin is the most-used sleep supplement but its evidence is strongest for falling asleep and shifting the body clock, not for staying asleep. Prolonged-release melatonin has legitimate trial support for sleep maintenance in people over 55, whose own production has declined. For the common 3am waking pattern, the higher-yield moves are cutting evening alcohol, screening for sleep apnoea and depression, and CBT for insomnia.

    Overview

    Melatonin is the most-used sleep supplement but its evidence is strongest for falling asleep and shifting the body clock, not for staying asleep. Prolonged-release melatonin has legitimate trial support for sleep maintenance in people over 55, whose own production has declined. For the common 3am waking pattern, the higher-yield moves are cutting evening alcohol, screening for sleep apnoea and depression, and CBT for insomnia.

    Verdict

    Mixed evidence

    Modest maintenance benefit with prolonged-release in older adults; weak for general night waking.

    How It Works

    Melatonin is the hormone of darkness, signalling the circadian system that night has begun. Prolonged-release formulations sustain levels across the night, modestly supporting sleep maintenance, while immediate-release forms act mainly at sleep onset.

    Dosing & Protocol

    Typical dose

    Recommended dose
    Prolonged-release 2 mg 1-2 hours before bed (over-55s); immediate-release is weaker for maintenance
    Expected timeframe
    1-2 weeks to judge effect

    Protocol

    form
    Immediate-release for sleep onset; prolonged-release is the formulation studied for sleep maintenance in adults over 55
    duration
    4 weeks, then reassess; prolonged-release is licensed for up to 13 weeks
    co factor
    Timing matters more than dose. Pair with a dark bedroom and no bright screens after dosing, since light suppresses the effect. Evidence is mixed: melatonin shifts sleep timing reliably but reduces night waking only modestly.
    titration
    Increase to 2 mg prolonged-release only if 1 mg is ineffective after two weeks - higher is not better
    starting dose
    0.5-1 mg taken 1-2 hours before the target bedtime

    Evidence

    What the studies say

    Meta-analyses show melatonin reduces sleep-onset latency reliably but increases total sleep time by only 10-20 minutes on average. Trials of prolonged-release 2 mg in over-55s with insomnia show meaningful improvements in sleep maintenance and morning alertness. Evidence for maintenance benefit in younger adults is weak, and supplement dose quality varies widely between products.

    Meta-analysis: melatonin for the treatment of primary sleep disorders

    Score: 8/10
    2013
    meta_analysis
    n=1683

    Ferracioli-Oda E, et al.

    This meta-analysis demonstrates that melatonin decreases sleep onset latency, increases total sleep time and improves overall sleep quality.

    View source

    Pharmacotherapies for sleep disturbances in dementia

    Score: 9/10
    2016
    systematic_review
    n=222

    McCleery J, et al.

    From single studies, we found no difference between melatonin and placebo groups for sleep efficiency, time awake after sleep onset, or number of night-time awakenings.

    View source

    Prolonged-release melatonin improves sleep quality and morning alertness in insomnia patients aged 55 years and older and has no withdrawal effects

    Score: 7/10
    2007
    rct
    n=170

    Lemoine P, et al.

    PR-melatonin is the first drug shown to significantly improve quality of sleep and morning alertness in primary insomnia patients aged 55 years and older.

    View source

    The effect of magnesium supplementation on primary insomnia in elderly: a double-blind placebo-controlled clinical trial

    Score: 5/10
    2012n=46

    Abbasi B, Kimiagar M, Sadeghniiat K +3 more

    Magnesium significantly increased sleep time and sleep efficiency and reduced Insomnia Severity Index scores, sleep onset latency and early morning awakening compared with placebo. Serum renin and melatonin increased and serum cortisol decreased in the magnesium group.

    View source

    Safety

    Caveats

    Product dose accuracy is poor in some markets; start low. Morning drowsiness signals too high a dose or too-late dosing. It does not treat sleep apnoea, alcohol-driven fragmentation or depression-related early waking.

    Less likely to help if

    People whose waking is driven by alcohol, untreated sleep apnoea, depression or nocturia — fix the driver instead.

    Medical Disclaimer

    The information provided on this website is for educational and informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or before starting any supplement regimen.

    Individual results may vary. The statements on this website have not been evaluated by the Food and Drug Administration. Products and information are not intended to diagnose, treat, cure, or prevent any disease.